← All stocks

Moderna

MRNA Scheduled selling only
CIK 0001682852 #318 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$16.86M
$0.00 on a plan · $16.86M straight out of an exercise
Sold at will
$0.00
0 of 5 sales
Net
−$16.86M
$0.00 against sales at will

By person

12 insiders · 5 transactions
1,362×

Stéphane Bancel holds 1,362 times base salary in stock. $2.29B of shares against $1.68M in salary for 2025.

Salary from the company's own proxy. The shares are what Stéphane Bancel last reported holding, valued at $146.07, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hoge Stephen
President
$11.69M (2) scheduled
−$11.69M
1,718,078
0.4303%
$250.96M
+7.4%
Mock James M
Chief Financial Officer
$4.69M (2) scheduled
−$4.69M
59,375
0.0149%
$8.67M
+577.3%
Klinger Shannon Thyme
Chief Legal Officer
$485.77K (1) scheduled
−$485.77K
81,340
0.0204%
$11.88M
+326.1%
Bancel Stephane
Chief Executive Officer
15,650,946
3.92%
$2.29B
+7.7%
SAGAN PAUL
Director
312,027
0.0782%
$45.58M
+11.3%
Nader Francois
Director
32,781
0.0082%
$4.79M
+59.1%
NABEL ELIZABETH G
Director
19,317
0.0048%
$2.82M
+817.7%
Horning Sandra
Director
18,585
0.0047%
$2.71M
+1,254%
Hussain Abbas
Director
12,066
0.0030%
$1.76M
Rubenstein David M.
Director
9,643
0.0024%
$1.41M
Tallett Elizabeth E
Director
4,761
0.0012%
$695.44K
+577.2%
AFEYAN NOUBAR
Director
3,924
0.0010%
$573.18K
0.0%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 238,187
History held since 13 Dec 2018